688217

Shanghai Rightongene Biotechnology
688217

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
CN¥1.65B
EV
CN¥1.44B
Shares Outstanding
55.19M
Beta
0.27
Industry
-

Wall Street View

Analyst Rating
BUY
Analyst Target Price
-
Number of Analysts
0
P/E 2025E
116.72x
P/Revenue 2025E
4.29x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Shanghai Rightongene Biotechnology Co., Ltd.

gainify
688217

Shanghai Rightongene Biotechnology Co., Ltd.

688217

Shanghai Rightongene Biotechnology Co., Ltd. engages in the research and development, production, and sale of in vitro diagnostic products. It also provides molecular diagnostic reagents, and scientific research and testing services for blood diseases, solid tumors, a...

Sector

Industry

CEO

Xiong, Hui

Employees

401

IPO Date

Headquarters

No. 147, Lane 1817, Huifeng West Road, Fengxian District, Shanghai 201403, China

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.